New FDA Guidance: Review of DMFs in Adva
The USFDA has published a new guidance titled “Review of Drug Master Files in Advance
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
